Clinical Trial Update: Use of Pharmacotherapy to Reduce Cue-responsiveness in Smokers [Phase 1]

View source ↗

Summary

A completed Phase 1 trial evaluating pharmacotherapy to reduce cue-responsiveness in individuals with nicotine or tobacco dependence. The sponsor is the Centre …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nicotine Dependence
• Tobacco Dependence

Snippet

Sponsor: Centre for Addiction and Mental Health | Conditions: Nicotine Dependence, Tobacco Dependence | Phase 1 | Status: COMPLETED